These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 2803914)

  • 1. Flow cytometric analysis of DNA content in human ovarian cancers.
    Erba E; Ubezio P; Pepe S; Vaghi M; Marsoni S; Torri W; Mangioni C; Landoni F; D'Incalci M
    Br J Cancer; 1989 Jul; 60(1):45-50. PubMed ID: 2803914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of long-term survival by flow cytometric analysis of cellular DNA content in patients with advanced ovarian cancer.
    Friedlander ML; Hedley DW; Swanson C; Russell P
    J Clin Oncol; 1988 Feb; 6(2):282-90. PubMed ID: 3276825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA index of ovarian carcinomas from 56 patients: in vivo in vitro studies.
    Erba E; Vaghi M; Pepe S; Amato G; Bistolfi M; Ubezio P; Mangioni C; Landoni F; Morasca L
    Br J Cancer; 1985 Oct; 52(4):565-73. PubMed ID: 4063134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of cellular DNA content on survival in ovarian carcinoma.
    Klemi PJ; Joensuu H; Mäenpää J; Kiilholma P
    Obstet Gynecol; 1989 Aug; 74(2):200-4. PubMed ID: 2748056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flow cytometric analysis of DNA and cell proliferation in ovarian tumors.
    Christov K; Vassilev N
    Cancer; 1988 Jan; 61(1):121-5. PubMed ID: 3334938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multivariate analysis of the prognostic significance of DNA-ploidy and S-phase fraction in ovarian cancer determined by flow cytometry following detection of cytokeratin-labeled tumor cells.
    Kimmig R; Wimberger P; Hillemanns P; Kapsner T; Caspari C; Hepp H
    Gynecol Oncol; 2002 Jan; 84(1):21-31. PubMed ID: 11748971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [DNA ploidy and results of first line chemotherapy in ovarian cancer patients].
    Milczek T; Klasa-Mazurkiewicz D; Emerich J; Debniak J
    Ginekol Pol; 2006 Aug; 77(8):589-96. PubMed ID: 17076189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ploidy as a prognostic factor in ovarian cancer.
    Friedlander ML; Taylor IW; Russell P; Musgrove EA; Hedley DH; Tattersall MH
    Int J Gynecol Pathol; 1983; 2(1):55-63. PubMed ID: 6307906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of DNA content in epithelial ovarian cancer.
    Gajewski WH; Fuller AF; Pastel-Ley C; Flotte TJ; Bell DA
    Gynecol Oncol; 1994 Apr; 53(1):5-12. PubMed ID: 8175021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumour ploidy, morphometry, histological grading and clinical features in ovarian carcinoma: mutual relations.
    Haapasalo H; Atkin NB; Collan Y; Pesonen E; Paljärvi L
    Anal Cell Pathol; 1991 Sep; 3(5):261-71. PubMed ID: 1931753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor DNA content as a prognostic feature in advanced epithelial ovarian carcinoma.
    Blumenfeld D; Braly PS; Ben-Ezra J; Klevecz RR
    Gynecol Oncol; 1987 Jul; 27(3):389-402. PubMed ID: 3623235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carcinoma of the anal canal and flow cytometric DNA analysis.
    Scott NA; Beart RW; Weiland LH; Cha SS; Lieber MM
    Br J Cancer; 1989 Jul; 60(1):56-8. PubMed ID: 2803916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Steroid hormone receptors and flow cytometric DNA ploidy in ovarian carcinoma.
    Grénman SE; Klemi P; Toikkanen S; Kaihola HL; Laippala P; Mäenpää J; Mäkinen J; Grönroos M
    Ann Chir Gynaecol Suppl; 1994; 208():15-9. PubMed ID: 8092763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular DNA content--a stable feature in epithelial ovarian cancer.
    Friedlander ML; Taylor IW; Russell P; Tattersall MH
    Br J Cancer; 1984 Feb; 49(2):173-9. PubMed ID: 6696818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selection of tumour cell subpopulations occurs during cultivation of human tumours in soft agar. A DNA flow cytometric study.
    Tveit KM; Pettersen EO; Fosså SD; Pihl A
    Br J Cancer; 1985 Nov; 52(5):701-5. PubMed ID: 4063145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flow cytometric analysis of cellular DNA content as an adjunct to the diagnosis of ovarian tumours of borderline malignancy.
    Friedlander ML; Russell P; Taylor IW; Hedley DW; Tattersall MH
    Pathology; 1984 Jul; 16(3):301-6. PubMed ID: 6514398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brenner tumours of the ovary: a study of the histology, immunohistochemistry and cellular DNA content in benign, borderline and malignant ovarian tumours.
    Trebeck CE; Friedlander ML; Russell P; Baird PJ
    Pathology; 1987 Jul; 19(3):241-6. PubMed ID: 3324024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA ploidy analysis of borderline epithelial ovarian tumours.
    Lodhi S; Najam S; Pervez S
    J Pak Med Assoc; 2000 Oct; 50(10):349-51. PubMed ID: 11109755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA flow cytometry, histological grade, stage, and age as prognostic factors in human epithelial ovarian carcinomas.
    Rutgers DH; Wils IS; Schaap AH; van Lindert AC
    Pathol Res Pract; 1987 Apr; 182(2):207-13. PubMed ID: 3601797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [DNA impulse cytophotometry measurements in head and neck tumors. Initial results of a correlation with clinical stage, therapeutic response and pattern of recurrence].
    Fietkau R; Iro H; Bilek P; Sauer R
    HNO; 1989 Feb; 37(2):62-6. PubMed ID: 2703374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.